Metabolic reprogramming in osteosarcoma
Pediatric Discovery · 2023
DOI: 10.1002/pdi3.18 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Discovery, 2023. Verfasst von Yulu Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology and Therapy Laboratory The Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health a…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tumor cells undergo metabolic reprogramming to meet their energy and anabolic demands to maintain their malignant phenotype. Activation of oncogenes and deletion of tumor suppressors promotes metabolic reprogramming in cancer by directly or indirectly regulating enzymatic activities associated with metabolic pathways. Metabolic reprogramming in tumor cells mainly involves the glycolytic pathway, pentose phosphate pathway, serine synthesis pathway, enhanced glutamine metabolism or fatty acid anabolism, and abnormal mitochondrial oxidative phosphorylation (OXPHOS). The tricarboxylic acid (TCA) cycle is the central pathway of mitochondrial OXPHOS, and glucose, amino acid and fatty acid metabolism are associated with the TCA cycle. Metabolic abnormalities and rewiring of metabolic pathways are also present in Osteosarcoma (OS). The abnormal metabolic pattern in OS is associated with cell proliferation, migration, invasion and drug resistance. This review summarizes the current studies on glycolysis, amino acid metabolism, lipid synthesis and the TCA cycle related to OS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cell Biology and Therapy Laboratory The Children's Hospital of Chongqing Medical University National Clinical Research Center for Child Health and Disorders Ministry of Education Key Laboratory of Child Development…
ORCID-Profile: Yulu Shi, Xiaohan Yue
Zitieren
APA
Shi, Y., Yue, X., & Luo, Q. (2023). Metabolic reprogramming in osteosarcoma. Pediatric Discovery. https://doi.org/10.1002/pdi3.18
Vancouver
Shi Y, Yue X, Luo Q. Metabolic reprogramming in osteosarcoma. Pediatric Discovery. 2023. doi:10.1002/pdi3.18
BibTeX
@article{Shi2023,
author = {Shi, Yulu and Yue, Xiaohan and Luo, Qing},
title = {Metabolic reprogramming in osteosarcoma},
journal = {Pediatric Discovery},
year = {2023},
doi = {10.1002/pdi3.18}
}
EUVIMED